Hepatic Encephalopathy in Liver Cirrhosis: Pathogenesis, Diagnosis and Management

Gerber, T.; Schomerus, H.
December 2000
Drugs;Dec2000, Vol. 60 Issue 6, p1353
Academic Journal
The pathogenesis of hepatic encephalopathy (HE) is unknown. Many theories have been proposed. Most established therapies are based on such theories but since no theory has have ever been proved, therapies have to be considered empiric. The spectrum of HE ranges from minimal cerebral functional deficits, which can only be found by sensitive psychometric tests, to coma with signs of decerebration. HE has arbitrarily been divided into stages. A number of precipitating factors are known and the first line of therapy should always be the elimination of these factors. The differential diagnosis includes all states of impaired consciousness and deficits in cerebral function in patients with chronic liver disease, and clinical and biochemical tests to differentiate are indicated. The therapeutic options for HE include: protein restriction only for a limited time in comatous patients; nonabsorbable antibiotics (aminoglycosides), which because of adverse effects are also limited to higher grades of HE; intestinal cleansing which is applicable in all degrees of HE; lactulose, branched chain aminoacids and ornithin aspartate which have been proven to be effective and can be applied long term in patients with lower grades of HE.


Related Articles

  • Review: Flumazenil leads to clinical and electroencephalographic improvement in hepatic encephalopathy in patients with cirrhosis. Reichen, Jurg // ACP Journal Club;Jan/Feb2003, Vol. 138 Issue 1, p15 

    Presents a study that investigated the effectiveness of flumazenil in treating hepatic encephalopathy in patients with cirrhosis. Data sources; Selection of studies used; Results and findings.

  • Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver. Jalan, R.; Kapoor, D. // Gut;Jul2003, Vol. 52 Issue 7, p1041 

    Background and aims: In patients with cirrhosis, hepatic encephalopathy is often precipitated by dehydration. This study tests the hypothesis that volume expansion in cirrhotic patients increases renal ammonia excretion. Patients and methods: Sixteen well compensated cirrhotic patients (mean...

  • Role of ammonia and inflammation in minimal hepatic encephalopathy. D. Shawcross; G. Wright; S. Olde Damink; R. Jalan // Metabolic Brain Disease;Mar2007, Vol. 22 Issue 1, p125 

    Abstract??Background:Minimal hepatic encephalopathy (MHE) is common in cirrhosis but its pathophysiologic basis remains undefined. We evaluated whether the presence of MHE was associated with severity of liver disease, ammonia levels or the presence of inflammation and assessed factors...

  • Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis Jover, Rodrigo; Compañy, Luís; Gutiérrez, Ana; Zapater, Pedro; Pérez-Serra, Juan; Girona, Eva; Aparicio, José R.; Pérez-Mateo, Miguel // American Journal of Gastroenterology;Jul2003, Vol. 98 Issue 7, p1599 

    : ObjectivesTwo types of neurological dysfunction can occur in compensated cirrhosis: 1) extrapyramidal signs related to the accumulation of manganese in the basal ganglia and 2) milder degrees of cognitive impairment known as minimal hepatic encephalopathy (mHE). We assessed whether there was...

  • Clinical effect and safety of TIPS in treatment of portal hypertension due to alcoholic cirrhosis. TANG Shanhong; QIN Jianping; JIANG Mingde // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 2, p145 

    To evaluate the clinical effect and safety of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension due to alcoholic cirrhosis. Methods A retrospective analysis was performed on the clinical data of 30 patients with portal hypertension due to alcoholic...

  • Increasing Prevalence of Gallstones in Male Veterans with Alcoholic Cirrhosis. Iber, Frank L.; Caruso, Gloria; Polepalle, Chandrasekhar; Kuchipudi, V.; Chinoy, Mumtaz // American Journal of Gastroenterology;Dec1990, Vol. 85 Issue 12, p1593 

    Cases of alcoholic cirrhosis identified at necropsy were studied for the prevalence and type of gallstones, compared with age- and race-matched autopsy controls. Data were examined from 1970-1977 and 1980-1987. In the early sample of 460 cirrhotic patients, 33% had gallstone disease, contrasted...

  • Noncompressive Myelopathy after Lienorenal Shunt in a Patient with Noncirrhotic Portal Fibrosis. Sarin, S. K.; Babu, S. // American Journal of Gastroenterology;Jul1983, Vol. 78 Issue 7, p440 

    Noncirrhotic portal fibrosis is a common cause of portal hypertension in India. We report the development of noncompressive myelopathy after a lienorenal shunt in a patient with noncirrhotic portal fibrosis.

  • Focal Neurological Signs in Cirrhotic Patients With Episodes of Hepatic Encephalopathy. Kyprianou, Annette; Hanna, Joseph; Mullen, Kevin D. // American Journal of Gastroenterology;Feb2001, Vol. 96 Issue 2, p273 

    Discusses a study that discovered the presence of focal neurological signs in cirrhotic patients experiencing episodes of hepatic encephalopathy (HE). Background on elements in HE; Information on the participants in the study; Results of the use of tomography in determining the patients' brain...

  • The Relative Contribution of Hepatic Encephalopathy to Burden in Patients With Cirrhosis. Parikh, Neehar; Butt, Zeeshan // American Journal of Gastroenterology;Mar2012, Vol. 107 Issue 3, p486 

    A letter to the editor is presented in response to the article "The multidimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers," by J. S. Bajaj and colleagues in the 2011 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics